Alpha DNA Investment Management’s MetLife MET Stock Holding History

Alpha DNA Investment Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,083	Closed	-$1.4M	–	181
2022 Q3	$1.4M	Buy	23,083 +19,859	+616%	+$1.27M	1.17%	13
2022 Q2	$202K	Buy	+3,224	New	+$213K	0.17%	115
2021 Q2	–	Sell	-725	Closed	-$44K	–	419
2021 Q1	$44K	Sell	725 -159	-18%	-$8.77K	0.05%	191
2020 Q4	$41K	Buy	+884	New	+$38.3K	0.04%	195

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's MET Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of MetLife (MET) in Q4 2022, closing a stake of 23,083 shares — an estimated $1.4M sold.

Alpha DNA Investment Management first reported a position in MET in Q4 2020 and held it in 4 quarters. The position peaked at $1.4M in Q3 2022. 1,314 funds tracked by Wall St. Rank hold MET as of Q4 2022.

Alpha DNA Investment Management reported no remaining MetLife position as of Q4 2022 after selling out during the quarter.
Alpha DNA Investment Management sold 23,083 MetLife shares in Q4 2022, an estimated $1.4M.
Alpha DNA Investment Management first reported a position in MetLife in Q4 2020 and held it in 4 quarters.
Alpha DNA Investment Management's MetLife position peaked at $1.4M in Q3 2022.
1,314 funds tracked by Wall St. Rank held MetLife as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.